字号·· | 护眼
路透社

消息人士:巴斯夫提高报价仍不足以收购赢创Higher offer from BASF will not suffice for Evonik takeover, sources say

点「原文对照」整页切到原文,或双击某段只看那段的原文。

2016年2月29日,德国特种化学品公司赢创工业集团(Evonik Industries AG)的标志拍摄于其位于德国比特费尔德的工厂。路透社/法布里齐奥·本施/资料图片The logo of German specialty chemical company Evonik Industries AG is pictured at their plant in Bitterfeld, Germany, February 29, 2016. REUTERS/Fabrizio Bensch/File Photo

两位接近赢创(EVKn.DE)的消息人士周三向路透社表示,巴斯夫(BASFn.DE)在纸面上提高报价将不足以实现对赢创的收购。消息人士称,达成交易需要令人信服的工业逻辑理由。

A higher offer on paper from BASF (BASFn.DE) will not be enough for a takeover of Evonik (EVKn.DE), two sources close to Evonik told Reuters on Wednesday. There would need to be a compelling industrial rationale for a deal, the sources said.

路透社看到的一份内部备忘录显示,赢创管理层告诉员工,依然坚信公司作为独立企业拥有强劲的未来。

In an internal memo seen by Reuters, Evonik's management told employees it remained convinced the company had a strong future as an independent business.

此前,德国商业出版物《商报》(Handelsblatt)援引金融业消息人士报道称,巴斯夫需要大幅提高对较小同行赢创的报价,每股26欧元至28欧元(约合29美元至31美元)的出价可能有助于打破僵局。赢创和巴斯夫均拒绝就该报道置评。

The news comes after German business publication Handelsblatt, citing financial industry sources, reported that BASF would need to significantly raise its offer for smaller peer Evonik, with a bid of €26 to €28 ($29 to $31) per share potentially helping to break the deadlock. Evonik and BASF declined to comment on the report.

阅读媒体原文 ↗